Ureidopropionic acid
Ureidopropionic acid structure
|
Common Name | Ureidopropionic acid | ||
|---|---|---|---|---|
| CAS Number | 462-88-4 | Molecular Weight | 132.11800 | |
| Density | 1.337g/cm3 | Boiling Point | 324.8ºC at 760mmHg | |
| Molecular Formula | C4H8N2O3 | Melting Point | 170-175ºC (dec.) | |
| MSDS | Chinese USA | Flash Point | 150.2ºC | |
Use of Ureidopropionic acidUreidopropionic acid is an intermediate in the metabolism of uracil. |
| Name | N-carbamoyl-β-alanine |
|---|---|
| Synonym | More Synonyms |
| Description | Ureidopropionic acid is an intermediate in the metabolism of uracil. |
|---|---|
| Related Catalog | |
| Target |
Human Endogenous Metabolite |
| Density | 1.337g/cm3 |
|---|---|
| Boiling Point | 324.8ºC at 760mmHg |
| Melting Point | 170-175ºC (dec.) |
| Molecular Formula | C4H8N2O3 |
| Molecular Weight | 132.11800 |
| Flash Point | 150.2ºC |
| Exact Mass | 132.05300 |
| PSA | 92.42000 |
| LogP | 0.22060 |
| Vapour Pressure | 4.87E-05mmHg at 25°C |
| Index of Refraction | 1.504 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Safety Phrases | S22 |
| RIDADR | NONH for all modes of transport |
| HS Code | 2924199090 |
|
~96%
Ureidopropionic acid CAS#:462-88-4 |
| Literature: Kravchenko; Maksareva; Belyakov; Sigachev; Chegaev; Lyssenko; Lebedev; Makhova Russian Chemical Bulletin, 2003 , vol. 52, # 1 p. 192 - 197 |
|
~%
Ureidopropionic acid CAS#:462-88-4 |
| Literature: Pojarlieff,I.G. Tetrahedron, 1967 , vol. 23, p. 4307 - 4315 |
|
~%
Ureidopropionic acid CAS#:462-88-4 |
| Literature: Lengfeld; Stieglitz American Chemical Journal, 1893 , vol. 15, p. 516 |
|
~%
Ureidopropionic acid CAS#:462-88-4 |
| Literature: Batt et al. Journal of the American Chemical Society, 1954 , vol. 76, p. 3663 |
|
~%
Ureidopropionic acid CAS#:462-88-4 |
| Literature: Cohn; Doherty Journal of the American Chemical Society, 1956 , vol. 78, p. 2863,2865 |
|
~%
Ureidopropionic acid CAS#:462-88-4 |
| Literature: Cohn; Doherty Journal of the American Chemical Society, 1956 , vol. 78, p. 2863,2865 |
| Precursor 7 | |
|---|---|
| DownStream 7 | |
![isopropyl 3-(4,6-dimethyl-2-oxo-3a,6a-diphenyl-5-thioxooctahydroimidazo[4,5-d]imidazol-1-yl)propanoate structure](https://www.chemsrc.com/caspic/108/1350618-27-7.png)
CAS#:1350618-27-7
CAS#:534-13-4
CAS#:134-81-6![methyl 3-(4,6-dimethyl-2-oxo-3a,6a-diphenyl-5-thioxooctahydroimidazo[4,5-d]imidazol-1-yl)propanoate structure](https://www.chemsrc.com/caspic/336/1350618-21-1.png)
CAS#:1350618-21-1
CAS#:123351-54-2
CAS#:105-55-5| HS Code | 2924199090 |
|---|---|
| Summary | 2924199090. other acyclic amides (including acyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
|
Improved colorimetric procedure for quantitating N-carbamoyl-beta-alanine with minimum dihydrouracil interference.
Anal. Biochem. 122(2) , 345-7, (1982)
|
|
|
Sensitive method for the quantification of urinary pyrimidine metabolites in healthy adults by gas chromatography-tandem mass spectrometry.
J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 791(1-2) , 371-80, (2003) Enzyme deficiencies in pyrimidine metabolism are associated with a risk for severe toxicity against the antineoplastic agent 5-fluorouracil. To assess whether urinary levels of pyrimidines and their m... |
|
|
Comprehensive analysis of pyrimidine metabolism in 450 children with unspecific neurological symptoms using high-pressure liquid chromatography-electrospray ionization tandem mass spectrometry.
J. Inherit. Metab. Dis. 28(6) , 1109-22, (2005) To evaluate the significance of inborn metabolic disorders of the pyrimidine degradation pathway, 450 children with unspecific neurological symptoms were comprehensively studied; 200 healthy children ... |
| 3-(carbamoylamino)propanoic acid |
| N-carbamoyl-beta-alanine |
| 3-Ureidopropionic Acid |